Invention Grant
- Patent Title: Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
- Patent Title (中): 可吸入的氨曲南用于治疗和预防肺细菌感染
-
Application No.: US14046539Application Date: 2013-10-04
-
Publication No.: US09533000B2Publication Date: 2017-01-03
- Inventor: Alan Bruce Montgomery
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: GILEAD SCIENCES, INC.
- Current Assignee: GILEAD SCIENCES, INC.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/12 ; A61K31/15 ; A61K31/426 ; A61K31/7036 ; A61K31/397 ; A61K31/427
Abstract:
A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam, or a pharmaceutically acceptable salt thereof, delivered as an aerosol or dry powder formulation.
Public/Granted literature
- US20140037735A1 INHALABLE AZTREONAM FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS Public/Granted day:2014-02-06
Information query
